Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jun 13;7(11):2375-2377.
doi: 10.1182/bloodadvances.2022008162.

Under-representation of classical hematology training on hematology-oncology fellowship program websites in the United States

Affiliations

Under-representation of classical hematology training on hematology-oncology fellowship program websites in the United States

Puja Panwar et al. Blood Adv. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest disclosure: The authors declare no competing financial interests.

Figures

Figure 1.
Figure 1.
Website listing of specialty interests of fellowship PDs.
Figure 2.
Figure 2.
Mention of “classical” hematology or similar term on fellowship website. Includes the terms non-malignant, benign, general, and/or non-cancerous.

References

    1. Todd RF, Gitlin SD, Burns LJ, the Committee on Training Programs Subspeciality training in hematology and oncology, 2003: results of a survey of training program directors conducted by the American Society of Hematology. Blood. 2004;103(12):4383–4388. - PubMed
    1. Masselink LE, Erikson CE, Connell NT, et al. Associations between hematology/oncology fellows’ training and mentorship experiences and hematology-only career plans. Blood Adv. 2019;3(21):3278–3286. - PMC - PubMed
    1. Kirkwood MK, Kosty MP, Bajorin DF, Bruinooge SS, Goldstein MA. Tracking the workforce: the American Society of Clinical Oncology workforce information system. J Oncol Pract. 2013;9(1):3–8. - PMC - PubMed
    1. Soffer E, Hoots WK. Challenges facing the benign hematology physician-scientist workforce: identifying issues of recruitment and retention. Blood Adv. 2018;2(3):308. - PMC - PubMed
    1. Loren A. Hematology and Goliath: ensuring the future of benign hematology in a world of combined hematology-oncology fellowships. Hematologist. 2009;6(4)